Search

everythinglearnresearchcommunity

for

Search:↓

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

IL-18 signaling helps mature Tregs move into the thymus.

TCDD changes skin cell growth and keratin production in mice.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

Yangyin Qingre Huoxue Prescription may help treat atherosclerosis with fewer liver side effects than simvastatin.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

The herbal hair serum with flaxseed and aloe vera effectively promotes hair health and treats common hair issues.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

The document's conclusion cannot be provided because the content is not accessible.

Increasing XIAP and DDRGK1 can help prevent hearing loss from loud noise.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

BCG site reactions after COVID-19 mRNA vaccination are mild, temporary, and likely under-reported.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

OCT4B1 and SOX-2 levels are higher in Crohn's and ulcerative colitis patients, possibly aiding tissue repair.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

A new patch can deliver stable antibodies over time for potential HIV treatment.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.